measuregroup/AID240422

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID123090165_AID240422_PMID15482914_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID194165553_AID240422_PMID15482914_VALUE6 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID174520176_AID240422_PMID15482914_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103221208_AID240422_PMID15482914_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103221208_AID240422_PMID15482914_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID194165553_AID240422_PMID15482914_VALUE5
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Effective dose required towards 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as the radioligand
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID123090165 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID194165553 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103221208 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID174520176
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID240422

Total number of triples: 14.